Implementation of a pharmacogenomics consult service to support the INGENIOUS trial

Michael Eadon, Zeruesenay Desta, Kenneth Levy, Brian Decker, Rc Pierson, Vm Pratt, John Callaghan, Marc Rosenman, Janet Carpenter, Ann Holmes, Ca Mcdonald, Eric Benson, As Patil, Raj Vuppalanchi, Bt Gufford, N. Dave, Jd Robarge, Ma Hyder, David Haas, Rolf KreutzPaul Dexter, Todd Skaar, Da Flockhart

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Successful implementation efforts have been modeled at many academic centers. In contrast, this report provides insights into the formation of a pharmacogenomics consultation service at a safety-net hospital, which predominantly serves low-income, uninsured, and vulnerable populations. The report describes the INdiana GENomics Implementation: an Opportunity for the UnderServed (INGENIOUS) trial and addresses concerns of adjudication, credentialing, and funding.

Original languageEnglish (US)
JournalClinical Pharmacology and Therapeutics
DOIs
StateAccepted/In press - 2016

Fingerprint

Safety-net Providers
Credentialing
Pharmacogenetics
Vulnerable Populations
Poverty
Genomics
Referral and Consultation
Pharmacogenomic Testing

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{78dfd95badf7478eb023a646d54e37c1,
title = "Implementation of a pharmacogenomics consult service to support the INGENIOUS trial",
abstract = "Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Successful implementation efforts have been modeled at many academic centers. In contrast, this report provides insights into the formation of a pharmacogenomics consultation service at a safety-net hospital, which predominantly serves low-income, uninsured, and vulnerable populations. The report describes the INdiana GENomics Implementation: an Opportunity for the UnderServed (INGENIOUS) trial and addresses concerns of adjudication, credentialing, and funding.",
author = "Michael Eadon and Zeruesenay Desta and Kenneth Levy and Brian Decker and Rc Pierson and Vm Pratt and John Callaghan and Marc Rosenman and Janet Carpenter and Ann Holmes and Ca Mcdonald and Eric Benson and As Patil and Raj Vuppalanchi and Bt Gufford and N. Dave and Jd Robarge and Ma Hyder and David Haas and Rolf Kreutz and Paul Dexter and Todd Skaar and Da Flockhart",
year = "2016",
doi = "10.1002/cpt.347",
language = "English (US)",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Implementation of a pharmacogenomics consult service to support the INGENIOUS trial

AU - Eadon, Michael

AU - Desta, Zeruesenay

AU - Levy, Kenneth

AU - Decker, Brian

AU - Pierson, Rc

AU - Pratt, Vm

AU - Callaghan, John

AU - Rosenman, Marc

AU - Carpenter, Janet

AU - Holmes, Ann

AU - Mcdonald, Ca

AU - Benson, Eric

AU - Patil, As

AU - Vuppalanchi, Raj

AU - Gufford, Bt

AU - Dave, N.

AU - Robarge, Jd

AU - Hyder, Ma

AU - Haas, David

AU - Kreutz, Rolf

AU - Dexter, Paul

AU - Skaar, Todd

AU - Flockhart, Da

PY - 2016

Y1 - 2016

N2 - Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Successful implementation efforts have been modeled at many academic centers. In contrast, this report provides insights into the formation of a pharmacogenomics consultation service at a safety-net hospital, which predominantly serves low-income, uninsured, and vulnerable populations. The report describes the INdiana GENomics Implementation: an Opportunity for the UnderServed (INGENIOUS) trial and addresses concerns of adjudication, credentialing, and funding.

AB - Hospital systems increasingly utilize pharmacogenomic testing to inform clinical prescribing. Successful implementation efforts have been modeled at many academic centers. In contrast, this report provides insights into the formation of a pharmacogenomics consultation service at a safety-net hospital, which predominantly serves low-income, uninsured, and vulnerable populations. The report describes the INdiana GENomics Implementation: an Opportunity for the UnderServed (INGENIOUS) trial and addresses concerns of adjudication, credentialing, and funding.

UR - http://www.scopus.com/inward/record.url?scp=84959902680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959902680&partnerID=8YFLogxK

U2 - 10.1002/cpt.347

DO - 10.1002/cpt.347

M3 - Article

C2 - 26850569

AN - SCOPUS:84959902680

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

ER -